Intra-Cellular Therapies, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/3/2025
Shares
840,269
Value ($000)
70,179
Weight
1.0%
2020 Q3 - 2024 Q4 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).